top of page
The Human Variable
Search


RAVYNS™ : Reporting Analysis Via Yielding, Neglect & Sabotage
When the full IACC population is included, the national total of adults likely experiencing medical sabotage, partner interference, or care-linked neglect rises to approximately 24 million. RAVYNS™ is the first integrated system to transform partner interference and institutional neglect in chronic-illness care into an auditable public-health metric.
Oct 29


How CYNAERA’s Terrain Frameworks Unlock Trillions in U.S. Federal Efficiency
By October 2025, CYNAERA’s federal-scale models identified between $1.05 trillion and $3.45 trillion in potential annual savings for the United States through modular frameworks that stabilize health, accelerate remission, and optimize budgetary flow across SSA, CMS, VA, and FEMA
Oct 19


The Uncounted: Vaccine Injury Prevalence, Economic Burden, and Reform
Using a multi-model estimation approach, we project that 8–12 million Americans may be experiencing chronic health impacts following vaccination, with 40–50 percent facing functional disability. The associated annual economic burden ranges from $100 to $500 billion. We propose that the adoption of immune-informed readiness protocols could prevent up to 1.6 million cases annually, saving $20–40 billion per year.
Aug 29


A Nobel-Scale Advance: AI-Powered CRISPR Platform to End Infection-Associated Chronic Conditions - Lite
A Nobel-scale leap, built outside the system. This isn’t just another CRISPR project. CYNAERA’s AI-powered gene editing platform was designed by a patient, for patients—modeling remission across millions of synthetic profiles to restore immune stability in infection-associated chronic conditions like Long COVID, ME/CFS, and MCAS.
It cuts years off clinical trial timelines. It eliminates $5–10 million in early development costs. It’s scalable and ethical globally. AI meets bio
May 8


The Science of Remission: Reversing the Terrain of Infection-Associated Chronic Conditions (IACCs)
Contrary to the conventional framing of remission as spontaneous or unachievable, this framework presents remission as a predictable biological outcome, emerging from synchronized interventions across immune, hormonal, mitochondrial, and environmental axes. The CYNAERA Remission Pathway™ outlines a five-phase stabilization and recovery model, while the STAIR: Stable Method™ offers pre-intervention protection for hypersensitive subgroups, including those with mast cell reacti
May 1


AI That Sees the Whole Picture: Tracking Symptoms and Consequences
As AI technology continues to revolutionize healthcare, one crucial aspect that cannot be overlooked is data privacy and security.
Apr 11
bottom of page
